• OPEN AN ACCOUNT
Indian Indices
Sensex
85,408.70 -116.14
( -0.14%)
Global Indices
Nasdaq
48,752.17 288.75
(0.60%)
Dow Jones
6,952.35 21.56
(0.31%)
Hang Seng
50,381.79 37.69
(0.07%)
Nikkei 225
9,870.68 -18.54
(-0.19%)
Forex
USD-INR
89.57 -0.04
(-0.05%)
EUR-INR
105.52 0.34
(0.32%)
GBP-INR
120.86 0.52
(0.43%)
JPY-INR
0.57 0.00
(0.60%)

EQUITY - MARKET SCREENER

Alembic Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
533573
INE901L01018
267.3488556
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
APLLTD
37.95
16850.37
EPS(TTM)
Face Value()
Div & Yield %
22.59
2
1.28
 

As on: Dec 24, 2025 12:00 AM

Last Price() Net Change (%) Volume (Nos) P / E
857.25 0.35 705 37.95
Stock Price Details
Open Price() 855.00
Best Buy () 0
Best Sell () 0
Buy Quantity (Nos) 0
Sell Quantity (Nos) 0
Today's High () 862.00
Today's Low () 854.50
52-Week High () 1122.4
152-Week Low () 725.6
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 1.28
Eps 22.59
Book Value 267.3488556
Market Cap (.Cr) 16,850.37
Face Value 2
Market Lot 1
AGM Date Aug
Book Closure Date
ISIN No. INE901L01018


News
Alembic Pharma receives USFDA approval for Travoprost ophthalmic solution
Sensex, Nifty trade with mild gains; European mrkt advance
Alembic receives USFDA approval for Travoprost Ophthalmic Solution
Alembic receives USFDA approval for Loteprednol Etabonate and Tobramycin Ophthalmic Suspension 0.5%/0.3%
Alembic Pharmaceuticals announces change in senior management
Volumes jump at DCM Shriram Ltd counter
Alembic Pharma gains after generic gets USFDA nod
Alembic Pharma receives USFDA approval for Diltiazem hydrochloride tablets
Alembic Pharma gets US FDA approval for angina treatment drug Diltiazem
Alembic Pharma receives USFDA nod for Dexlansoprazole Delayed-Release Capsules
More
Corporate Details
Incoporation Year   : 2010
Chairman : Chirayu R Amin
Bussiness Group : Indian Private
Registered Office
Alembic Pharmaceuticals Ltd
Alembic Road,
,
Vadodara,
Gujarat-390003
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-0265-2280550
Fax:91-0265-2282506
Fax:91-22-66317458
E-Mail : apl.investors@alembic.co.in
URL : http://www.alembicpharmaceuticals.com/


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
  • BSE 500
  • BSE HC
  • BSE SmallCap
  • CNX 500
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi